Advertisement

Epidemiology and Site-Specific Risk Factors for Oral Cancer

  • Newell W. JohnsonEmail author
  • Bhawna Gupta
  • Anura Ariyawardana
  • Hemantha Amarasinghe
Chapter

Abstract

To outline the global epidemiology of oral cancer and recent changes in disease prevalence with the emergence of HPV-induced cancers

References

  1. 1.
    Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36(10):575–80.Google Scholar
  2. 2.
    Johnson NW, Warnakulasuriya S, Gupta PC, Dimba E, Chindia M, Otoh EC, et al. Global oral health inequalities in incidence and outcomes for oral cancer: causes and solutions. Adv Dent Res. 2011;23(2):237–46.PubMedGoogle Scholar
  3. 3.
    Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers CD, et al. Cancer incidence and mortality worldwide. Lyon: International Agency for Research on Cancer; 2012. Available from: http://globocan.iarc.fr.Google Scholar
  4. 4.
    Satyanarayana L, Asthana S. Life time risk for development of ten major cancers in India and its trends over the years 1982 to 2000. Indian J Med Sci. 2008;62(2):35–44.PubMedGoogle Scholar
  5. 5.
    Gupta B, Ariyawardana A, Johnson NW. Oral cancer in India continues in epidemic proportions: evidence base and policy initiatives. Int Dent J. 2013;63(1):12–25.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Gupta PC, Nandakumar A. Oral cancer scene in India. Oral Dis. 1999;5(1):1–2.PubMedGoogle Scholar
  7. 7.
    Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71–96.Google Scholar
  8. 8.
    Moore SR, Allister J, Roder D, Pierce AM, Wilson DF. Lip cancer in South Australia, 1977–1996. Pathology. 2001;33(2):167–71.PubMedGoogle Scholar
  9. 9.
    Nemes JA, Redl P, Boda R, Kiss C, Marton IJ. Oral cancer report from Northeastern Hungary. Pathol Oncol Res. 2008;14(1):85–92.PubMedGoogle Scholar
  10. 10.
    Tanaka S, Sobue T. Comparison of oral and pharyngeal cancer mortality in five countries: France, Italy, Japan, UK and USA from the WHO Mortality Database (1960–2000). Jpn J Clin Oncol. 2005;35(8):488–91.PubMedGoogle Scholar
  11. 11.
    Bosetti C, Bertuccio P, Levi F, Lucchini F, Negri E, La Vecchia C. Cancer mortality in the European Union, 1970–2003, with a joinpoint analysis. Ann Oncol. 2008;19(4):631–40.PubMedGoogle Scholar
  12. 12.
    National Cancer Registry Programme. Development of an Atlas of cancer in India: World Health Organization; 2010. Available from: http://www.canceratlasindia.org/chapter1_1.aspx.
  13. 13.
    Wunsch-Filho V, de Camargo EA. The burden of mouth cancer in Latin America and the Caribbean: epidemiologic issues. Semin Oncol. 2001;28(2):158–68.PubMedGoogle Scholar
  14. 14.
    Brandizzi D, Chuchurru JA, Lanfranchi HE, Cabrini RL. Analysis of the epidemiological features of oral cancer in the city of Buenos Aires. Acta Odontol Latinoam. 2005;18(1):31–5.PubMedGoogle Scholar
  15. 15.
    Ariyawardana A, Johnson NW. Trends of lip, oral cavity and oropharyngeal cancers in Australia 1982–2008: overall good news but with rising rates in the oropharynx. BMC Cancer. 2013;13:333.PubMedPubMedCentralGoogle Scholar
  16. 16.
    Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer. 2008;44(10):1345–89.PubMedGoogle Scholar
  17. 17.
    Conway DI, Stockton DL, Warnakulasuriya KA, et al. Incidence of oral and oropharyngeal cancer in United Kingdom (1990–1999) – recent trends and regional variation. Oral Oncol. 2006;42(6):586–92.PubMedGoogle Scholar
  18. 18.
    Hashibe M, Brennan P, Chuang SC, et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomark Prev. 2009;18:541–50.Google Scholar
  19. 19.
    Gupta B, Johnson NW. Systematic review and meta-analysis of association of smokeless tobacco and of betel quid without tobacco with incidence of oral cancer in South Asia and the Pacific. PLoS One. 2014;9(11), e113385.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Gan LL, Zhang H, Guo JH, Fan MW. Prevalence of human papillomavirus infection in oral squamous cell carcinoma: a case–control study in Wuhan, China. Asian Pac J Cancer Prev. 2014;15(14):5861–5.PubMedGoogle Scholar
  21. 21.
    Liu L, Kumar SK, Sedghizadeh PP, Jayakar AN, Shuler CF. Oral squamous cell carcinoma incidence by subsite among diverse racial and ethnic populations in California. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105(4):470–80.PubMedGoogle Scholar
  22. 22.
    Reichman ME, Kelly JJ, Kosary CL, Coughlin SS, Jim MA, Lanier AP. Incidence of cancers of the oral cavity and pharynx among American Indians and Alaska Natives, 1999–2004. Cancer. 2008;113(5 Suppl):1256–65.PubMedGoogle Scholar
  23. 23.
    Nichols AC, Bhattacharyya N. Racial differences in stage and survival in head and neck squamous cell carcinoma. Laryngoscope. 2007;117(5):770–5.PubMedGoogle Scholar
  24. 24.
    Gourin CG, Podolsky RH. Racial disparities in patients with head and neck squamous cell carcinoma. Laryngoscope. 2006;116(7):1093–106.PubMedGoogle Scholar
  25. 25.
    Suarez E, Calo WA, Hernandez EY, Diaz EC, Figueroa NR, Ortiz AP. Age-standardized incidence and mortality rates of oral and pharyngeal cancer in Puerto Rico and among Non-Hispanics Whites, Non-Hispanic Blacks, and Hispanics in the USA. BMC Cancer. 2009;9:129.PubMedPubMedCentralGoogle Scholar
  26. 26.
    Ayo-Yusuf OA, Lalloo R, Johnson NW. Trends and ethnic disparities in oral and oro-pharyngeal cancers in South Africa, 1992–2001. SADJ. 2013;68(4):168–73.PubMedGoogle Scholar
  27. 27.
    Moles DR, Fedele S, Speight PM, Porter SR, dos Santos Silva I. Oral and pharyngeal cancer in South Asians and non-South Asians in relation to socioeconomic deprivation in South East England. Br J Cancer. 2008;98(3):633–5.PubMedPubMedCentralGoogle Scholar
  28. 28.
    Chhetri DK, Rawnsley JD, Calcaterra TC. Carcinoma of the buccal mucosa. Otolaryngol Head Neck Surg. 2000;123(5):566–71.PubMedGoogle Scholar
  29. 29.
    Diaz Jr EM, Holsinger FC, Zuniga ER, Roberts DB, Sorensen DM. Squamous cell carcinoma of the buccal mucosa: one institution’s experience with 119 previously untreated patients. Head Neck. 2003;25(4):267–73.PubMedGoogle Scholar
  30. 30.
    Iyer SG, Pradhan SA, Pai PS, Patil S. Surgical treatment outcomes of localized squamous carcinoma of buccal mucosa. Head Neck. 2004;26(10):897–902.PubMedGoogle Scholar
  31. 31.
    Liao CT, Wang HM, Ng SH, Yen TC, Lee LY, Hsueh C, et al. Good tumor control and survivals of squamous cell carcinoma of buccal mucosa treated with radical surgery with or without neck dissection in Taiwan. Oral Oncol. 2006;42(8):800–9.PubMedGoogle Scholar
  32. 32.
    Lin CS, Jen YM, Cheng MF, Lin YS, Su WF, Hwang JM, et al. Squamous cell carcinoma of the buccal mucosa: an aggressive cancer requiring multimodality treatment. Head Neck. 2006;28(2):150–7.PubMedGoogle Scholar
  33. 33.
    Sieczka E, Datta R, Singh A, Loree T, Rigual N, Orner J, et al. Cancer of the buccal mucosa: are margins and T-stage accurate predictors of local control? Am J Otolaryngol. 2001;22(6):395–9.PubMedGoogle Scholar
  34. 34.
    National Cancer Institute: Surveillance Epidemiology and End Results (SEER). SEER cancer statistics review 1975–2004. Available from: http://seer.cancer.gov/statfacts/html/oralcav.html.
  35. 35.
    Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for squamous cell carcinoma of the oral cavity in young people--a comprehensive literature review. Oral Oncol. 2001;37(5):401–18.PubMedGoogle Scholar
  36. 36.
    Annertz K, Anderson H, Biorklund A, Moller T, Kantola S, Mork J, et al. Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults. Int J Cancer. 2002;101(1):95–9.PubMedGoogle Scholar
  37. 37.
    Schantz SP, Yu GP. Head and neck cancer incidence trends in young Americans, 1973–1997, with a special analysis for tongue cancer. Arch Otolaryngol Head Neck Surg. 2002;128(3):268–74.PubMedGoogle Scholar
  38. 38.
    Warnakulasuriya S, Mak V, Moller H. Oral cancer survival in young people in South East England. Oral Oncol. 2007;43(10):982–6.PubMedGoogle Scholar
  39. 39.
    Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20–44 years. Cancer. 2005;103(9):1843–9.PubMedGoogle Scholar
  40. 40.
    Scully C, Bedi R. Ethnicity and oral cancer. Lancet Oncol. 2000;1(1):37–42.PubMedPubMedCentralGoogle Scholar
  41. 41.
    Robinson KL, Macfarlane GJ. Oropharyngeal cancer incidence and mortality in Scotland: are rates still increasing? Oral Oncol. 2003;39(1):31–6.PubMedGoogle Scholar
  42. 42.
    Elango JK, Gangadharan P, Sumithra S, Kuriakose MA. Trends of head and neck cancers in urban and rural India. Asian Pac J Cancer Prev. 2006;7(1):108–12.PubMedGoogle Scholar
  43. 43.
    Hirota SK, Braga FP, Penha SS, Sugaya NN, Migliari DA. Risk factors for oral squamous cell carcinoma in young and older Brazilian patients: a comparative analysis. Med Oral Patol Oral Cir Bucal. 2008;13(4):E227–31.PubMedGoogle Scholar
  44. 44.
    World Health Organization: Mortality database. Available from: http://www-dep.iarc.fr/WHOdb/WHOdb.htm.
  45. 45.
    La Vecchia C, Lucchini F, Negri E, Levi F. Trends in oral cancer mortality in Europe. Oral Oncol. 2004;40(4):433–9.PubMedGoogle Scholar
  46. 46.
    Morse DE, Kerr AR. Disparities in oral and pharyngeal cancer incidence, mortality and survival among black and white Americans. J Am Dent Assoc. 2006;137(2):203–12.PubMedPubMedCentralGoogle Scholar
  47. 47.
    Moore RJ, Doherty DA, Do KA, Chamberlain RM, Khuri FR. Racial disparity in survival of patients with squamous cell carcinoma of the oral cavity and pharynx. Ethn Health. 2001;6(3–4):165–77.PubMedGoogle Scholar
  48. 48.
    Sunny L, Yeole BB, Hakama M, Shiri R, Sastry PS, Mathews S, et al. Oral cancers in Mumbai, India: a fifteen years perspective with respect to incidence trend and cumulative risk. Asian Pac J Cancer Prev. 2004;5(3):294–300.PubMedGoogle Scholar
  49. 49.
    van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 2009;45(4–5):317–23.Google Scholar
  50. 50.
    Napier SS, Cowan CG, Gregg TA, Stevenson M, Lamey PJ, Toner PG. Potentially malignant oral lesions in Northern Ireland: size (extent) matters. Oral Dis. 2003;9(3):129–37.PubMedGoogle Scholar
  51. 51.
    Amarasinghe HK, Usgodaarachchi US, Johnson NW, Lalloo R, Warnakulasuriya S. Betel-quid chewing with or without tobacco is a major risk factor for oral potentially malignant disorders in Sri Lanka: a case–control study. Oral Oncol. 2010;46(4):297–301.PubMedGoogle Scholar
  52. 52.
    Chung CH, Yang YH, Wang TY, Shieh TY, Warnakulasuriya S. Oral precancerous disorders associated with areca quid chewing, smoking, and alcohol drinking in southern Taiwan. J Oral Pathol Med. 2005;34(8):460–6.Google Scholar
  53. 53.
    Thomas SJ, Harris R, Ness AR, Taulo J, Maclennan R, Howes N, et al. Betel quid not containing tobacco and oral leukoplakia: a report on a cross-sectional study in Papua New Guinea and a meta-analysis of current evidence. Int J Cancer. 2008;123(8):1871–6.PubMedGoogle Scholar
  54. 54.
    Petti S. Pooled estimate of world leukoplakia prevalence: a systematic review. Oral Oncol. 2003;39(8):770–80.Google Scholar
  55. 55.
    Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med. 2008;37(1):1–10.Google Scholar
  56. 56.
    Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med. 2003;14(1):47–62.Google Scholar
  57. 57.
    Pindborg JJ, Mehta FS, Daftary DK. Incidence of oral cancer among 30,000 villagers in India in a 7-year follow-up study of oral precancerous lesions. Community Dent Oral Epidemiol. 1975;3(2):86–8.PubMedGoogle Scholar
  58. 58.
    Silverman Jr S, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer. 1984;53(3):563–8.PubMedGoogle Scholar
  59. 59.
    Warnakulasuriya S, Kovacevic T, Madden P, Coupland VH, Sperandio M, Odell E, et al. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England. J Oral Pathol Med. 2011;40(9):677–83.PubMedGoogle Scholar
  60. 60.
    Sperandio M, Brown AL, Lock C, Morgan PR, Coupland VH, Madden PB, et al. Predictive value of dysplasia grading and DNA ploidy in malignant transformation of oral potentially malignant disorders. Cancer Prev Res (Phila). 2013;6(8):822–31.Google Scholar
  61. 61.
    Liu W, Shi LJ, Wu L, Feng JQ, Yang X, Li J, et al. Oral cancer development in patients with leukoplakia – clinicopathological factors affecting outcome. PLoS One. 2012;7(4), e34773.PubMedPubMedCentralGoogle Scholar
  62. 62.
    Ho MW, Risk JM, Woolgar JA, Field EA, Field JK, Steele JC, et al. The clinical determinants of malignant transformation in oral epithelial dysplasia. Oral Oncol. 2012;48(10):969–76.PubMedGoogle Scholar
  63. 63.
    Fitzpatrick SG, Hirsch SA, Gordon SC. The malignant transformation of oral lichen planus and oral lichenoid lesions: a systematic review. J Am Dent Assoc. 2014;145(1):45–56.PubMedGoogle Scholar
  64. 64.
    Brouns E, Baart J, Karagozoglu K, Aartman I, Bloemena E, van der Waal I. Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients. Oral Dis. 2014;20(3):e19–24.PubMedGoogle Scholar
  65. 65.
    Warnakulasuriya S. Causes of oral cancer – an appraisal of controversies. Br Dent J. 2009;207(10):471–5.PubMedGoogle Scholar
  66. 66.
    Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45(4–5):309–16.PubMedPubMedCentralGoogle Scholar
  67. 67.
    Gupta B, Johnson NW. Emerging and established global life-style risk factors for cancer of the upper aero-digestive tract. Asian Pac J Cancer Prev. 2014;15(15):5983–91.PubMedGoogle Scholar
  68. 68.
    Petti S. Lifestyle risk factors for oral cancer. Oral Oncol. 2009;45(4–5):340–50.PubMedPubMedCentralGoogle Scholar
  69. 69.
    Lin WJ, Jiang RS, Wu SH, Chen FJ, Liu SA. Smoking, alcohol, and betel quid and oral cancer: a prospective cohort study. J Oncol. 2011;2011:525976.PubMedPubMedCentralGoogle Scholar
  70. 70.
    Bhawna G. Burden of smoked and smokeless tobacco consumption in India – results from the Global Adult Tobacco Survey India (GATS-India) – 2009–201. Asian Pac J Cancer Prev. 2013;14(5):3323–9.PubMedGoogle Scholar
  71. 71.
    International Agency on Research on for Cancer. IARC Monographs on the evaluation of carcinogenic risks to humans, Alcohol consumption and ethyl carbamate. Monograph, vol. 96. Lyon: IARC; 2010.Google Scholar
  72. 72.
    Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko V, et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysis. Br J Cancer. 2015;112(3):580–93.Google Scholar
  73. 73.
    Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988;48(11):3282–7.PubMedGoogle Scholar
  74. 74.
    International Agency for Research on Cancer. Working Group on the Evaluation of Carcinogenic Risks to Humans, World Health Organization, International Agency for Research on Cancer. Smokeless tobacco and some tobacco-specific N-nitrosamines: World Health Organization; 2007.Google Scholar
  75. 75.
    International Agency for Research on Cancer. IARC Monographs on the evaluation of carcinogenic risks to humans. Betel-quid and Areca nut chewing and some Areca-nut derived Nitrosamines Monograph, vol. 85. Lyon: IARC; 2004.Google Scholar
  76. 76.
    Scientific Committee on Emerging and Newly Identified Health Risk (SCENIHR), European Commission. 2008. Available from: http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_013.pdf.
  77. 77.
    Hebbar PB, Sheshaprasad R, Gurudath S, Pai A, Sujatha D. Oral submucous fibrosis in India: are we progressing?? Indian J Cancer. 2014;51(3):222–6.PubMedGoogle Scholar
  78. 78.
    Kerr AR, Warnakulasuriya S, Mighell AJ, Dietrich T, Nasser M, Rimal J, et al. A systematic review of medical interventions for oral submucous fibrosis and future research opportunities. Oral Dis. 2011;17 Suppl 1:42–57.Google Scholar
  79. 79.
    Helen-Ng LC, Razak IA, Ghani WM, Marhazlinda J, Norain AT, Raja Jallaludin RL, et al. Dietary pattern and oral cancer risk – a factor analysis study. Community Dent Oral Epidemiol. 2012;40(6):560–6.PubMedGoogle Scholar
  80. 80.
    D’Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case–control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356(19):1944–56.PubMedPubMedCentralGoogle Scholar
  81. 81.
    Andrews E, Seaman WT, Webster-Cyriaque J. Oropharyngeal carcinoma in non-smokers and non-drinkers: a role for HPV. Oral Oncol. 2009;45(6):486–91.PubMedGoogle Scholar
  82. 82.
    Mirghani H, Amen F, Moreau F, Lacau St Guily J. Do high-risk human papillomaviruses cause oral cavity squamous cell carcinoma? Oral Oncol. 2015;51(3):229–36.PubMedGoogle Scholar
  83. 83.
    Ndiaye C, Mena M, Alemany L, Arbyn M, Castellsague X, Laporte L, et al. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol. 2014;15(12):1319–31.PubMedGoogle Scholar
  84. 84.
    Zheng TZ, Boyle P, Hu HF, Duan J, Jiang PJ, Ma DQ, et al. Tobacco smoking, alcohol consumption, and risk of oral cancer: a case–control study in Beijing, People’s Republic of China. Cancer Causes Control. 1990;1(2):173–9.PubMedGoogle Scholar
  85. 85.
    Rotundo LD, Toporcov TN, Biazevic GH, de Carvalho MB, Kowalski LP, Antunes JL. Are recurrent denture-related sores associated with the risk of oral cancer? A case control study. Rev Bras Epidemiol. 2013;16(3):705–15.PubMedGoogle Scholar
  86. 86.
    Ahrens W, Pohlabeln H, Foraita R, Nelis M, Lagiou P, Lagiou A, et al. Oral health, dental care and mouthwash associated with upper aerodigestive tract cancer risk in Europe: the ARCAGE study. Oral Oncol. 2014;50(6):616–25.PubMedGoogle Scholar
  87. 87.
    Elmore JG, Horwitz RI. Oral cancer and mouthwash use: evaluation of the epidemiologic evidence. Otolaryngol Head Neck Surg. 1995;113(3):253–61.PubMedGoogle Scholar
  88. 88.
    McCullough MJ, Farah CS. The role of alcohol in oral carcinogenesis with particular reference to alcohol-containing mouthwashes. Aust Dent J. 2008;53(4):302–5.PubMedGoogle Scholar
  89. 89.
    Guha N, Boffetta P, Wunsch Filho V, Eluf Neto J, Shangina O, Zaridze D, et al. Oral health and risk of squamous cell carcinoma of the head and neck and esophagus: results of two multicentric case–control studies. Am J Epidemiol. 2007;166(10):1159–73.PubMedGoogle Scholar
  90. 90.
    Gandini S, Negri E, Boffetta P, La Vecchia C, Boyle P. Mouthwash and oral cancer risk quantitative meta-analysis of epidemiologic studies. Ann Agric Environ Med. 2012;19(2):173–80.PubMedGoogle Scholar
  91. 91.
    Currie S, Farah C. Alcohol-containing mouthwash and oral cancer risk: a review of current evidence. OA Alcohol. 2014;2(1):4.1–9.Google Scholar
  92. 92.
    Kenborg L, Jorgensen AD, Budtz-Jorgensen E, Knudsen LE, Hansen J. Occupational exposure to the sun and risk of skin and lip cancer among male wage earners in Denmark: a population-based case–control study. Cancer Causes Control. 2010;21(8):1347–55.PubMedGoogle Scholar
  93. 93.
    Maruccia M, Onesti MG, Parisi P, Cigna E, Troccola A, Scuderi N. Lip cancer: a 10-year retrospective epidemiological study. Anticancer Res. 2012;32(4):1543–6.PubMedGoogle Scholar
  94. 94.
    Dasanayake AP, Silverman AJ, Warnakulasuriya S. Mate drinking and oral and oro-pharyngeal cancer: a systematic review and meta-analysis. Oral Oncol. 2010;46(2):82–6.PubMedGoogle Scholar
  95. 95.
    Deneo-Pellegrini H, De Stefani E, Boffetta P, Ronco AL, Acosta G, Correa P, et al. Mate consumption and risk of oral cancer: case–control study in Uruguay. Head Neck. 2013;35(8):1091–5.PubMedGoogle Scholar
  96. 96.
    Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370(9581):59–67.PubMedGoogle Scholar
  97. 97.
    Ohman J, Rexius H, Mjornstedt L, Gonzalez H, Holmberg E, Dellgren G, et al. Oral and lip cancer in solid organ transplant patients – a cohort study from a Swedish Transplant Centre. Oral Oncol. 2015;51(2):146–50.PubMedGoogle Scholar
  98. 98.
    Petti S, Masood M, Scully C. The magnitude of tobacco smoking-betel quid chewing-alcohol drinking interaction effect on oral cancer in South-East Asia. A meta-analysis of observational studies. PLoS One. 2013;8(11), e78999.PubMedPubMedCentralGoogle Scholar
  99. 99.
    Zini A, Czerninski R, Sgan-Cohen HD. Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites. J Oral Pathol Med. 2010;39(4):299–305.PubMedGoogle Scholar
  100. 100.
    Farah CS, Simanovic B, Dost F. Oral cancer in Australia 1982–2008: a growing need for opportunistic screening and prevention. Aust Dent J. 2014;59(3):349–59.PubMedGoogle Scholar
  101. 101.
    Souza RL, Fonseca-Fonseca T, Oliveira-Santos CC, Correa GT, Santos FB, Cardoso CM, et al. Lip squamous cell carcinoma in a Brazilian population: epidemiological study and clinicopathological associations. Med Oral Patol Oral Cir Bucal. 2011;16(6):e757–62.PubMedGoogle Scholar
  102. 102.
    Pukkala E, Notkola V. Cancer incidence among Finnish farmers, 1979–93. Cancer Causes Control. 1997;8(1):25–33.PubMedGoogle Scholar
  103. 103.
    Wiklund K, Dich J. Cancer risks among male farmers in Sweden. Eur J Cancer Prev. 1995;4(1):81–90.PubMedGoogle Scholar
  104. 104.
    Antoniades DZ, Styanidis K, Papanayotou P, Trigonidis G. Squamous cell carcinoma of the lips in a northern Greek population. Evaluation of prognostic factors on 5-year survival rate – I. Eur J Cancer B Oral Oncol. 1995;31B(5):333–9.PubMedGoogle Scholar
  105. 105.
    Sankaranarayanan R. Oral cancer in India: an epidemiologic and clinical review. Oral Surg Oral Med Oral Pathol. 1990;69(3):325–30.PubMedGoogle Scholar
  106. 106.
    Perea-Milla Lopez E, Minarro-Del Moral RM, Martinez-Garcia C, Zanetti R, Rosso S, Serrano S, et al. Lifestyles, environmental and phenotypic factors associated with lip cancer: a case–control study in southern Spain. Br J Cancer. 2003;88(11):1702–7.PubMedPubMedCentralGoogle Scholar
  107. 107.
    Pogoda JM, Preston-Martin S. Solar radiation, lip protection, and lip cancer risk in Los Angeles County women (California, United States). Cancer Causes Control. 1996;7(4):458–63.PubMedGoogle Scholar
  108. 108.
    Kesminiene A, Schuz JR. Radiation: ionizing, ultraviolet and electromagnetic. WHO Press Geneva: Stewart BW, Wild CP (sritors); 2014. p. 143–50.Google Scholar
  109. 109.
    Lopez-Pintor RM, Hernandez G, de Arriba L, de Andres A. Lip cancer in renal transplant patients. Oral Oncol. 2011;47(1):68–71.PubMedGoogle Scholar
  110. 110.
    van Leeuwen MT, Grulich AE, McDonald SP, McCredie MR, Amin J, Stewart JH, et al. Immunosuppression and other risk factors for lip cancer after kidney transplantation. Cancer Epidemiol Biomarkers Prev. 2009;18(2):561–9.PubMedGoogle Scholar
  111. 111.
    Friedman GD, Asgari MM, Warton EM, Chan J, Habel LA. Antihypertensive drugs and lip cancer in non-Hispanic whites. Arch Intern Med. 2012;172(16):1246–51.PubMedGoogle Scholar
  112. 112.
    Moore SR, Johnson NW, Pierce AM, Wilson DF. The epidemiology of tongue cancer: a review of global incidence. Oral Dis. 2000;6(2):75–84.PubMedGoogle Scholar
  113. 113.
    Pednekar MS, Gupta PC, Yeole BB, Hebert JR. Association of tobacco habits, including bidi smoking, with overall and site-specific cancer incidence: results from the Mumbai cohort study. Cancer Causes Control. 2011;22(6):859–68.PubMedPubMedCentralGoogle Scholar
  114. 114.
    Barasch A, Morse DE, Krutchkoff DJ, Eisenberg E. Smoking, gender, and age as risk factors for site-specific intraoral squamous cell carcinoma. A case-series analysis. Cancer. 1994;73(3):509–13.PubMedGoogle Scholar
  115. 115.
    Dhar PK, Rao TR, Sreekumaran Nair N, Mohan S, Chandra S, Bhat KR, et al. Identification of risk factors for specific subsites within the oral and oropharyngeal region--a study of 647 cancer patients. Indian J Cancer. 2000;37(2–3):114–22.PubMedGoogle Scholar
  116. 116.
    Zheng T, Holford T, Chen Y, Jiang P, Zhang B, Boyle P. Risk of tongue cancer associated with tobacco smoking and alcohol consumption: a case–control study. Oral Oncol. 1997;33(2):82–5.PubMedGoogle Scholar
  117. 117.
    Bodner L, Manor E, Friger MD, van der Waal I. Oral squamous cell carcinoma in patients twenty years of age or younger – review and analysis of 186 reported cases. Oral Oncol. 2014;50(2):84–9.PubMedGoogle Scholar
  118. 118.
    Siriwardena BS, Tilakaratne A, Amaratunga EA, Tilakaratne WM. Demographic, aetiological and survival differences of oral squamous cell carcinoma in the young and the old in Sri Lanka. Oral Oncol. 2006;42(8):831–6.PubMedGoogle Scholar
  119. 119.
    Pentenero M, Giaretti W, Navone R, Rostan I, Gassino L, Broccoletti R, et al. Evidence for a possible anatomical subsite-mediated effect of tobacco in oral potentially malignant disorders and carcinoma. J Oral Pathol Med. 2011;40(3):214–7.PubMedGoogle Scholar
  120. 120.
    Dahlgren L, Dahlstrand HM, Lindquist D, Hogmo A, Bjornestal L, Lindholm J, et al. Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer. 2004;112(6):1015–9.PubMedGoogle Scholar
  121. 121.
    Salem A. Dismissing links between HPV and aggressive tongue cancer in young patients. Ann Oncol. 2010;21(1):13–7.PubMedGoogle Scholar
  122. 122.
    D’Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis. 2009;199(9):1263–9.PubMedPubMedCentralGoogle Scholar
  123. 123.
    Radoï L, Paget-Bailly S, Cyr D, Papadopoulos A, Guida F, Schmaus A, et al. Tobacco smoking, alcohol drinking and risk of oral cavity cancer by subsite: results of a French population-based case–control study, the ICARE study. Eur J Cancer Prev. 2013;22(3):268–76.PubMedGoogle Scholar
  124. 124.
    Barasch A, Gofa A, Krutchkoff DJ, Eisenberg E. Squamous cell carcinoma of the gingiva. A case series analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;80(2):183–7.PubMedGoogle Scholar
  125. 125.
    Sankaranarayanan R, Duffy SW, Padmakumary G, Day NE, Padmanabhan TK. Tobacco chewing, alcohol and nasal snuff in cancer of the gingiva in Kerala, India. Br J Cancer. 1989;60(4):638–43.PubMedPubMedCentralGoogle Scholar
  126. 126.
    Idris AM, Nair J, Friesen M, Ohshima H, Brouet I, Faustman EM, et al. Carcinogenic tobacco-specific nitrosamines are present at unusually high levels in the saliva of oral snuff users in Sudan. Carcinogenesis. 1992;13(6):1001–5.PubMedGoogle Scholar
  127. 127.
    Nair J, Ohshima H, Friesen M, Croisy A, Bhide SV, Bartsch H. Tobacco-specific and betel nut-specific N-nitroso compounds: occurrence in saliva and urine of betel quid chewers and formation in vitro by nitrosation of betel quid. Carcinogenesis. 1985;6(2):295–303.PubMedGoogle Scholar
  128. 128.
    Warnakulasuriya S, Sutherland G, Scully C. Tobacco, oral cancer, and treatment of dependence. Oral Oncol. 2005;41(3):244–60.PubMedGoogle Scholar
  129. 129.
    Personal habits and indoor combustions, vol. 100 E. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt E):1–538.Google Scholar
  130. 130.
    Scheifele C, Reichart PA, Dietrich T. Low prevalence of oral leukoplakia in a representative sample of the US population. Oral Oncol. 2003;39(6):619–25.PubMedGoogle Scholar
  131. 131.
    Ministry of Health Sri Lanka: National Oral Health Survey, Sri Lanka (2002/2003). Colombo, 3rd publication 2009.Google Scholar
  132. 132.
    Garcia-Pola Vallejo MJ, Martinez Diaz-Canel AI, Garcia Martin JM, Gonzalez GM. Risk factors for oral soft tissue lesions in an adult Spanish population. Community Dent Oral Epidemiol. 2002;30(4):277–85.PubMedGoogle Scholar
  133. 133.
    Nagao T, Ikeda N, Fukano H, Miyazaki H, Yano M, Warnakulasuriya S. Outcome following a population screening programme for oral cancer and precancer in Japan. Oral Oncol. 2000;36(4):340–6.Google Scholar
  134. 134.
    Zain RB, Ikeda N, Razak IA, Axell T, Majid ZA, Gupta PC, et al. A national epidemiological survey of oral mucosal lesions in Malaysia. Community Dent Oral Epidemiol. 1997;25(5):377–83.PubMedGoogle Scholar
  135. 135.
    Schepman KP, van der Meij EH, Smeele LE, van der Waal I. Prevalence study of oral white lesions with special reference to a new definition of oral leucoplakia. Eur J Cancer B Oral Oncol. 1996;32(6):416–9.Google Scholar
  136. 136.
    Banoczy J, Rigo O. Prevalence study of oral precancerous lesions within a complex screening system in Hungary. Community Dent Oral Epidemiol. 1991;19(5):265–7.PubMedGoogle Scholar
  137. 137.
    Ikeda N, Ishii T, Iida S, Kawai T. Epidemiological study of oral leukoplakia based on mass screening for oral mucosal diseases in a selected Japanese population. Community Dent Oral Epidemiol. 1991;19(3):160–3.PubMedGoogle Scholar
  138. 138.
    Axell T. Occurrence of leukoplakia and some other oral white lesions among 20,333 adult Swedish people. Community Dent Oral Epidemiol. 1987;15(1):46–51.PubMedGoogle Scholar
  139. 139.
    Axell T, Rundquist L. Oral lichen planus – a demographic study. Community Dent Oral Epidemiol. 1987;15(1):52–6.PubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 2.5 International License (http://creativecommons.org/licenses/by-nc/2.5/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

The images or other third party material in this chapter are included in the chapter's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the chapter's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

Authors and Affiliations

  • Newell W. Johnson
    • 1
    Email author
  • Bhawna Gupta
    • 1
  • Anura Ariyawardana
    • 2
    • 3
  • Hemantha Amarasinghe
    • 4
  1. 1.Gold Coast Campus of Griffith UniversityNathanAustralia
  2. 2.Menzies Health Institute of QueenslandGold Coast Campus, Griffith UniversityGold CoastAustralia
  3. 3.College of Medicine and DentistryJames Cook UniversityCairnsAustralia
  4. 4.Institute of Oral HealthMaharagamaSri Lanka

Personalised recommendations